TATE Versus TACE, an Open-label Randomized Study Comparing TransArterial Tirapazamine Embolization Versus TransArterial ChemoEmbolization in Intermediate Stage Hepatocellular Carcinoma
Phase of Trial: Phase II
Latest Information Update: 08 May 2018
At a glance
- Drugs Tirapazamine (Primary) ; Doxorubicin; Ethiodized oil
- Indications Liver cancer
- Focus Therapeutic Use
- Sponsors Teclison
- 30 Apr 2018 Planned End Date changed from 31 Oct 2020 to 31 Oct 2021.
- 30 Apr 2018 Planned primary completion date changed from 31 Oct 2019 to 31 May 2020.
- 13 Nov 2017 Planned number of patients changed from 114 to 134.